Name: Latest research reports of Krishna Institute of Medical Sciences Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Krishna Institute of Medical Sciences Ltd.
Rating: 5
Author: Axis Direct

Krishna Institute of Medical Sciences Ltd.

NSE: KIMS | BSE: 543308 | ISIN: INE967H01025 | Industry: Healthcare Facilities
| Expensive Performer

616.7500 22.60 (3.80%)

NSE Apr 11, 2025 15:31 PM

76.21% Gain from 52W Low

Volume: 658.1K

Krishna Institute of Medical Sciences Ltd.

12 Nov 2024, 12:00AM

616.75

3.80%

Result Update:Krishna Institu.

Buy: Krishna Institute of Medic...

Axis Direct

we maintain a BUY rating with a target price of Rs 615/share with a valuation of 21x EV/EBITDA for Sep 27E. The TP implies an upside potential of 10% from the CMP.

Krishna Institute of Medical Sciences Ltd. is trading above all available SMAs

The Baseline | 11 Apr 2025, 05:20PM

Market closes higher, Aurobindo Pharma's US plant gets Form 483 with 11 FDA observations

Trendlyne Marketwatch | 11 Apr 2025, 04:01PM

Krishna Institute of Medical Sciences: A low-debt but highly valued private healthcare play

| 16 Jun 2021